Bit Origin
BTOG
Bakkt Holdings
BKKT
Bitdeer Technologies
BTDR
SATO TECHNOLOGIES CORP
CCPUF
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
JAZZ Jazz Pharmaceuticals
- 124.250
- +1.280+1.04%
Close Dec 23 16:00 ET
- 123.420
- -0.830-0.67%
Post 16:05 ET
7.51BMarket Cap17.60P/E (TTM)
124.630High121.995Low411.01KVolume122.810Open122.970Pre Close50.89MTurnover0.70%Turnover Ratio20.37P/E (Static)60.45MShares134.17052wk High1.80P/B7.29BFloat Cap99.06052wk Low--Dividend TTM58.67MShs Float194.730Historical High--Div YieldTTM2.14%Amplitude0.515Historical Low123.822Avg Price1Lot Size
About Jazz Pharmaceuticals Company
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Company Profile
SymbolJAZZ
Company NameJazz Pharmaceuticals
Listing DateJun 1, 2007
Issue Price18.00
Founded2005
CEOMr. Bruce C. Cozadd
MarketNASDAQ
Employees2800
Fiscal Year Ends12-31
AddressWaterloo Exchange,Waterloo Road,5th Floor
CityDublin
ProvinceDublin
CountryIreland
Zip Code4
Phone353-1-634-7800
Company Executives
- Name
- Position
- Salary
- Bruce C. Cozadd
- Chairman of the Board and Chief Executive Officer
- 15.34M
- Patricia Carr
- Senior Vice President and Chief Accounting Officer
- 1.40M
- Renee D. Gala
- President and Chief Operating Officer
- 5.43M
- Neena M. Patil
- Executive Vice President and Chief Legal Officer
- 3.88M
- Philip L. Johnson
- Executive Vice President and Chief Financial Officer
- --
- Samantha Pearce
- Senior Vice President, Europe and International
- --
- Dr. Robert Iannone, M.D.
- Executive Vice President and Global Head of Research and Development
- 4.98M
- Liz Henderson
- Senior Vice President, Technical Operations
- --
- Heather Ann McSharry
- Independent Director
- 543.77K
- Anne O'Riordan
- Independent Director
- 523.77K
- Rick E. Winningham
- Lead Independent Director
- 571.27K
- Kenneth W. O'Keefe
- Independent Director
- 513.77K
- Laura J. Hamill
- Independent Director
- --
- Jennifer E. Cook
- Independent Director
- 533.77K
- Patrick Thomas Kennedy
- Independent Director
- --
- Dr. Norbert G. Riedel,PhD
- Independent Director
- 533.77K
- Seamus C. Mulligan
- Independent Director
- 531.27K
- Dr. Mark D. Smith, M.D.
- Independent Director
- 521.27K
- Patrick G. Enright, M.B.A.
- Independent Director
- 526.27K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.